azathioprine has been researched along with Idiopathic Parkinson Disease in 5 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Excerpt | Relevance | Reference |
---|---|---|
"Treatment with prednisone and azathioprine did not give any improvement of the neurological symptoms." | 1.29 | Hemiparkinsonism in a patient with primary Sjögren's syndrome. A case report and a review of the literature. ( Koudstaal, PJ; van de Merwe, JP; Visser, LH, 1993) |
"Two patients presented with a subacute confusional state, two with dementia, and one with depression." | 1.28 | Neuropsychiatric systemic lupus erythematosus in elderly people: a case series. ( Bendall, P; Byrne, EJ; Dennis, MS; Hopkinson, N, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Greenland, JC | 1 |
Cutting, E | 1 |
Kadyan, S | 1 |
Bond, S | 1 |
Chhabra, A | 1 |
Williams-Gray, CH | 1 |
Kannoth, S | 1 |
Anandakkuttan, A | 1 |
Mathai, A | 1 |
Sasikumar, AN | 1 |
Nambiar, V | 1 |
Levin, N | 1 |
Karussis, D | 1 |
Abramsky, O | 1 |
Visser, LH | 1 |
Koudstaal, PJ | 1 |
van de Merwe, JP | 1 |
Dennis, MS | 1 |
Byrne, EJ | 1 |
Hopkinson, N | 1 |
Bendall, P | 1 |
1 trial available for azathioprine and Idiopathic Parkinson Disease
Article | Year |
---|---|
Azathioprine immunosuppression and disease modification in Parkinson's disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol.
Topics: Azathioprine; Double-Blind Method; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Park | 2020 |
4 other studies available for azathioprine and Idiopathic Parkinson Disease
Article | Year |
---|---|
Autoimmune atypical parkinsonism - A group of treatable parkinsonism.
Topics: Aged; Autoimmune Diseases; Azathioprine; Female; Glutamate Decarboxylase; Humans; Immunosuppressive | 2016 |
Parkinson's disease associated with myasthenia gravis. A report of 4 cases.
Topics: Aged; Azathioprine; Cholinesterase Inhibitors; Drug Therapy, Combination; Female; Humans; Immunosupp | 2003 |
Hemiparkinsonism in a patient with primary Sjögren's syndrome. A case report and a review of the literature.
Topics: Azathioprine; Brain; Corpus Striatum; Female; Humans; Immunoglobulin A; Immunoglobulin G; Immunoglob | 1993 |
Neuropsychiatric systemic lupus erythematosus in elderly people: a case series.
Topics: Aged; Aged, 80 and over; Azathioprine; Confusion; Dementia; Diagnosis, Differential; Drug Therapy, C | 1992 |